Skip to content

Evaluation of safety and the effectiveness of Bioba (Prime) anti-hair loss line (serum and shampoo)

Evaluation of safety and the effectiveness of Bioba (Prime) anti-hair loss line (serum and shampoo) in reducing diffuse and scattered hair loss and Improving hair volume and density

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT20190210042676N16
Enrollment
19
Registered
2021-12-11
Start date
2021-12-22
Completion date
Unknown
Last updated
2022-01-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hair loss. Nonscarring hair loss, unspecified

Interventions

Intervention group: Topical use of Bioba(Prime) anti-hair loss serum produced by Akhavi laboratory (Contains Concentrated Silatol, Decarboxy carnosine, B vitamins and baobab seed oil) Spray 9 times o

Sponsors

Akhavi laboratory
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 55 Years

Inclusion criteria

Inclusion criteria: Male or female aged 18-55 years Diffuse and scattered hair loss (Count at least 300 hairs in a combing test over three days) General health Voluntary participation and signing written informed consent

Exclusion criteria

Exclusion criteria: Chronic active scalp disease other than hair loss Using any prescribed drug or OTC for hair loss within the past 3 months Any severe weight loss or strict diet therapy during the study Pregnancy or breastfeeding

Design outcomes

Primary

MeasureTime frame
Hair count changes. Timepoint: Before intervention, 6 and 12 weeks after the start of use. Method of measurement: Trichoscopy By Fotofinder.

Secondary

MeasureTime frame
Hair lost Changes, based on Global photographic review. Timepoint: Before intervention, 6 and 12 weeks after the start of use. Method of measurement: One independent dermatologist will perform clinical assessments in a blinded fashion by scoring every photograph according to the Global photographic review scale .;Changes in percentage of anagen to telogen. Timepoint: Before intervention, 6 and 12 weeks the start of use. Method of measurement: Trichoscopy By Fotofinder.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAniseh Samadi

Tehran University of Medical Sciences

aniseh_samadi@yahoo.com+98 21 8896 0880

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026